Novo Nordisk A/S (NYSE:NVO) Q4 2023 Earnings Call Transcript January 31, 2024 Novo Nordisk A/S beats earnings expectations. Reported EPS is $4.91, expectations were $0.66. NVO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank you for […]